---
title: "aisidi has established a new digital technology company in Nanjing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/241778560.md"
description: "According to the Qichacha APP, recently, Nanjing Kuso Digital Technology Co., Ltd. was established, with Ji Gang as the legal representative. The business scope includes: sales of communication equipment; sales of mobile communication equipment; sales of wearable smart devices; sales of electrical accessories, etc. Qichacha's equity penetration shows that the company is wholly owned by aisidi indirectly"
datetime: "2025-05-26T03:22:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/241778560.md)
  - [en](https://longbridge.com/en/news/241778560.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/241778560.md)
generator: "portal-rs"
---

# aisidi has established a new digital technology company in Nanjing

According to the Qichacha APP, recently, Nanjing Kuso Digital Technology Co., Ltd. was established, with Ji Gang as the legal representative. The business scope includes: sales of communication equipment; sales of mobile communication equipment; sales of wearable smart devices; sales of electrical accessories, etc. Qichacha's equity penetration shows that the company is wholly owned by aisidi indirectly

### Related Stocks

- [002416.CN](https://longbridge.com/en/quote/002416.CN.md)

## Related News & Research

- [ROI-Europe's autumn reckoning — bonds, budgets, billionaires: Mike Dolan](https://longbridge.com/en/news/296992818.md)
- [Canada minister says he welcomes US clarification on French language requirements](https://longbridge.com/en/news/297196718.md)
- [Heidelberg Pharma, Huadong Medicine expand ADC collaboration to develop new drug candidates](https://longbridge.com/en/news/297291658.md)
- [Faron Pharmaceuticals releases H1 2026 results webcast transcript](https://longbridge.com/en/news/297049228.md)
- [Heidelberg Pharma says China NMPA clears HDP-101 combo trial in multiple myeloma](https://longbridge.com/en/news/297070749.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**